BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37933810)

  • 21. Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Yu AC; Afework DD; Goldstein JD; Abemayor E; Mendelsohn AH
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1029-1037. PubMed ID: 36136328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review.
    Dowthwaite S; Jackson J; Dzienis M; Khoo E; Cronin M; Guazzo E
    Curr Oncol Rep; 2023 May; 25(5):501-510. PubMed ID: 36881215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
    Au VH; Miller LE; Mitchell MB; Larson AR; Lin DT; Feng AL; Richmon JD
    Am J Otolaryngol; 2024; 45(1):104074. PubMed ID: 37865986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR
    Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
    Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
    Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
    Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
    Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation and outcomes of patients with clinically T1-2, N0 oropharynx squamous cell carcinoma: The interplay of primary treatment modality and human papillomavirus status.
    Al-Qurayshi Z; Zhu VL; Bayon R; Buchakjian MR
    Head Neck; 2023 Jan; 45(1):64-74. PubMed ID: 36205359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
    Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma.
    Carey RM; Prasad A; Wei K; Brant JA; Brody RM; Leibowitz JM; Civantos FJ; Sweeny L
    Laryngoscope; 2024 May; 134(5):2243-2251. PubMed ID: 37947342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Options for Locally Advanced Oropharyngeal Cancer.
    Qureshi HA; Abouyared M; Barber B; Houlton JJ
    Curr Treat Options Oncol; 2019 Apr; 20(5):36. PubMed ID: 30931485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.